← Browse by Condition
Medical Condition
solid cancer
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1
NCT06763159 Phase 1
Recruiting
A Study of HS-20124 in Patients with Advanced Solid Tumors
Enrollment
450 pts
Location
China
Sponsor
Hansoh BioMedical R&D Company
NCT07161310
Recruiting
Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors
Enrollment
45 pts
Location
Germany
Sponsor
Goethe University
NCT06730386 Phase 1
Recruiting
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
Enrollment
100 pts
Location
Australia
Sponsor
Akeso